Table 5.
Proposed Scales for Intraoperative Quantification of Surgical Complexity in Early NSCLC After Neoadjuvant Immunotherapy
| Grade | Characteristics |
|---|---|
| Nonmalignant lymphadenopathy | |
| 0 | Lymphadenopathy <1 cm |
| 1 | Lymphadenopathy 1 to <2 cm |
| 2 | Lymphadenopathy 2 to <3 cm |
| 3 | Lymphadenopathy ≥3 cm |
| Peripheral (pleural) fibrosis | |
| 1 | Mild fibrosis (no substantial impact on conduct of surgical resection) |
| 2 | Moderate fibrosis (requires increased effort and dissection during resection but otherwise does not severely impact the conduct of the surgery) |
| 3 | Severe fibrosis (substantially impacts the conduct of the operation by increasing the duration of or blood loss during the surgery, or requires converting minimally invasive to open surgery) |
| 4 | Severe fibrosis resulting in unresectability |
| Central vs. peripheral lung cancer | |
| 1 | Central (inner two-thirds of lung) |
| 2 | Peripheral (outer two-thirds of lung) |
| Perihilar/lobar or mediastinal adhesions | |
| 1 | Mild fibrosis (no substantial impact on conduct of surgical resection) |
| 2 | Moderate fibrosis (requires increased effort and dissection during resection but otherwise does not severely impact the conduct of the surgery) |
| 3 | Severe fibrosis (substantially impacts the conduct of the operation by increasing the duration of or blood loss during the surgery, or requires converting minimally invasive to open surgery) |
| 4 | Severe fibrosis resulting in unresectability |